MannKind Corporation (NASDAQ:MNKD) announced the pricing of a registered direct public offering of up to 48,543,692 shares of common stock and warrants to …
MannKind Corporation (NASDAQ:MNKD) reported financial results for the first quarter ended March 31, 2016. For the first quarter of 2016, total operating expenses were …
It’s an eventful week ahead for pharmaceutical companies MannKind Corporation (NASDAQ:MNKD), Allergan plc Ordinary Shares (NYSE:AGN), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), and Horizon Pharma PLC …
Healthcare analysts give their two cents on recent updates by MannKind Corporation (NASDAQ:MNKD) and Dynavax Technologies Corporation (NASDAQ:DVAX). One analyst remains on the …
MannKind Corporation (NASDAQ:MNKD) announced two senior appointments to its commercial organization. Joining the Company are Joseph Saldanha as Vice President of Marketing and Agustin …
It was a busy week for biotech investors as several players released earnings, for better or worse. Namely, all eyes were on Valeant …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and MannKind Corporation (NASDAQ:MNKD) both know what it’s like to be the fan favorites in the biotech sector. …
The iShares Nasdaq Biotechnology ETF (IBB) ended 3.8 percent lower Tuesday, as investors reacted harshly toward poor earnings results by pharma giant Valeant Pharmaceuticals …
Linn Energy LLC (NASDAQ:LINE) is falling 29% in pre-market trading after the company posted disappointing Q4:15 revenues earlier this morning. The company reported …
Partnership terminations, government investigations, pipeline updates, and advancements in new products mark this week’s earnings reports from Valeant Pharmaceuticals Intl Inc (NYSE:VRX), MannKind Corporation …
